U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07648290) titled 'Self-Start Triage Model for Post-Botox(R) Lower Urinary Tract Symptoms' on June 10.
Brief Summary: The primary objective of this study is to investigate whether providing a standing, take-home prescription for empiric Macrobid (self-start model) is superior to standard call-in/urgent care triage (triage model) among patients undergoing intradetrusor Botox(R). Urinary tract infections. (UTIs) are the most common complication with intradetrusor Botox(R), and patients have to call in to the triage line or present to a health care facility to be evaluated. Thus, the research team will compare Unplanned Healthcare Utilization, i.e. the f...